DEBORAH HAMMOND: Open Payments
NPI 1417436999 · PONTIAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,002 in 96 payments from 13 companies in 2025. Trend: 2023 $1,159 · 2024 $1,119 · 2025 $2,002
Food & beverage: $1,893Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $308 |
| E.R. Squibb & Sons, L.L.C. | 15 | $305 |
| Alkermes, Inc. | 9 | $282 |
| Indivior Inc. | 8 | $222 |
| Vanda Pharmaceuticals Inc. | 11 | $201 |
| Otsuka America Pharmaceutical, Inc. | 17 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $136 |
| ABBVIE INC. | 5 | $117 |
| Lundbeck LLC | 4 | $99 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
Products named: COBENFY, SUBLOCADE, FANAPT, REXULTI, UZEDY, CAPLYTA, LYBALVI, VRAYLAR.
Industry payments across MI — which companies pay providers there.
